Nonetheless, recent literature suggested that sodium-glucose cotransporter-2 inhibitors, despite an initial alarm, may exert favorable effects on AKI in patients without diabetes mellitus [30]. The gene discussed is SLC5A2; the disease is acute kidney injury.